Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference32 articles.
1. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium;Ball;Gynecol Oncol,1996
2. Taxol;McGuire;Ann Internal Med,1989
3. Phase II of taxol in patients with ovarian carcinoma progressive after prior chemotherapy;Thigpen;J Clin Oncol,1994
4. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer;Holmes;J Natl Cancer Inst,1991
5. Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer;Reichman;J Clin Oncol,1993
Cited by 143 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Complete radiological response when using pembrolizumab in the mono mode in the 2nd-line drug therapy of MSI-h / dMMR-positive advanced endometrial cancer. A clinical case;Surgery and Oncology;2023-12-21
2. A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer;Gynecologic Oncology;2023-11
3. An Overview of Endometrial Cancer with Novel Therapeutic Strategies;Current Oncology;2023-08-27
4. Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration Service in England;International Journal of Gynecologic Cancer;2023-08-24
5. Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study;Clinical Cancer Research;2023-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3